Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 2/2008

01-02-2008

Pancreatic VIPomas: Subject Review and One Institutional Experience

Authors: Amir A. Ghaferi, Karen A. Chojnacki, William D. Long, John L. Cameron, Charles J. Yeo

Published in: Journal of Gastrointestinal Surgery | Issue 2/2008

Login to get access

Abstract

VIPomas are rare pancreatic endocrine tumors associated with a well-defined clinical syndrome characterized by watery diarrhea, hypokalemia, and metabolic acidosis. The objective of this study was to review a single institution’s experience with VIPomas, as well as to review the English literature. A retrospective review of the Johns Hopkins pancreatic database revealed four cases of VIPoma, with three patients being male. All patients presented with watery diarrhea, hypokalemia, hypercalcemia, and acidosis. All patients had no family history of multiple endocrine neoplasia. Computed tomography revealed the primary pancreatic tumor in all patients, with three tumors located in the tail of the pancreas. One tumor involved the entire pancreas. Computed tomography and/or octreotide radionuclide scans identified hepatic metastasis in three patients. Mean serum vasoactive intestinal polypeptide levels were 683 pg/ml (range 293 to 1,500 pg/ml). All patients underwent resection of the pancreatic primary tumor. Two patients also had simultaneous liver resections. All patients had evidence of malignancy as defined by the presence of metastatic lymph nodes and/or hepatic metastases. Two patients had complete resolution of symptoms after surgical resection. One patient required radioablation of liver metastases and adjuvant octreotide therapy for control of symptoms. One patient died of progressive metastatic disease 96 months after surgery, whereas the other three remain alive. Extended, meaningful survival can be achieved for VIPoma patients, combining an aggressive surgical approach with additional strategies for treatment of unresected disease.
Literature
1.
go back to reference Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am 1987;67:379.PubMed Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am 1987;67:379.PubMed
2.
go back to reference Mekhijian HS, O’Dorisio TM. VIPoma syndrome. Semin Oncol 1987;14:282–291. Mekhijian HS, O’Dorisio TM. VIPoma syndrome. Semin Oncol 1987;14:282–291.
3.
go back to reference Capella C, Polak JM, Buffa R, Tapia FJ, Heitz P, Usellini L, Bloom SR, Solcia E. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases. Cancer 1983;52(10):1860–1874.PubMedCrossRef Capella C, Polak JM, Buffa R, Tapia FJ, Heitz P, Usellini L, Bloom SR, Solcia E. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases. Cancer 1983;52(10):1860–1874.PubMedCrossRef
4.
go back to reference Ectors N. Pancreatic endocrine tumors: diagnostic pitfalls. Hepatogastroenterology 1999;46:679.PubMed Ectors N. Pancreatic endocrine tumors: diagnostic pitfalls. Hepatogastroenterology 1999;46:679.PubMed
5.
go back to reference Priest WM, Alexander MK. Islet cell tumor of the pancreas with peptic ulceration, diarrhea and hypokalemia. Lancet 1957;273:1145–1147.PubMedCrossRef Priest WM, Alexander MK. Islet cell tumor of the pancreas with peptic ulceration, diarrhea and hypokalemia. Lancet 1957;273:1145–1147.PubMedCrossRef
6.
go back to reference Verner JV, Morrison AB. Islet cell tumour and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958;25:374.PubMedCrossRef Verner JV, Morrison AB. Islet cell tumour and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958;25:374.PubMedCrossRef
7.
go back to reference Bloom SR, Polak JM, Pearse AGE. Vasoactive intestinal peptide and watery-diarrhea syndrome. Lancet 1973;2:14–16.PubMedCrossRef Bloom SR, Polak JM, Pearse AGE. Vasoactive intestinal peptide and watery-diarrhea syndrome. Lancet 1973;2:14–16.PubMedCrossRef
8.
go back to reference Kane MG, O’Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med 1983;309:1482–1485.PubMedCrossRef Kane MG, O’Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med 1983;309:1482–1485.PubMedCrossRef
9.
go back to reference Holst JJ, Fahrenkrug J, Knuhtsen S, Jensen SL, Poulsen SS, Nielsen OV. Vasoactive intestinal peptide (VIP) in the pig pancreas: role of VIPergic nerves in the control of fluid and bicarbonate secretion. Regul Pept 1984;8:245.PubMedCrossRef Holst JJ, Fahrenkrug J, Knuhtsen S, Jensen SL, Poulsen SS, Nielsen OV. Vasoactive intestinal peptide (VIP) in the pig pancreas: role of VIPergic nerves in the control of fluid and bicarbonate secretion. Regul Pept 1984;8:245.PubMedCrossRef
10.
go back to reference Robberecht P, Conlon TP, Gardner JD. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3′,5′-monophosphate. J Biol Chem 1976;251:4635.PubMed Robberecht P, Conlon TP, Gardner JD. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3′,5′-monophosphate. J Biol Chem 1976;251:4635.PubMed
11.
12.
go back to reference Fahrenkrug J. Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol 1993;72:354.PubMed Fahrenkrug J. Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol 1993;72:354.PubMed
13.
go back to reference Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 1984;73:963.PubMedCrossRef Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 1984;73:963.PubMedCrossRef
14.
go back to reference Usdin TB, Bonner TI, Mezey É. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994;135:2662.PubMedCrossRef Usdin TB, Bonner TI, Mezey É. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994;135:2662.PubMedCrossRef
15.
go back to reference Koberstein B, Layer P, Balzer K, Muller MK, Singer MV, Goebell H. Paralytic ileus responding to somatostatin therapy: First manifestation of a VIPoma. Dig Dis Sci 1989;34(11):1803–1804.PubMedCrossRef Koberstein B, Layer P, Balzer K, Muller MK, Singer MV, Goebell H. Paralytic ileus responding to somatostatin therapy: First manifestation of a VIPoma. Dig Dis Sci 1989;34(11):1803–1804.PubMedCrossRef
16.
go back to reference Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998;17(4):389–400.PubMed Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998;17(4):389–400.PubMed
17.
go back to reference Smith SL, Branton SA, Avino AJ, Martin JK, Klingler PJ, Thompson GB, Grant CS, van Heerden JA. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998;124(6):1050–1055.PubMedCrossRef Smith SL, Branton SA, Avino AJ, Martin JK, Klingler PJ, Thompson GB, Grant CS, van Heerden JA. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998;124(6):1050–1055.PubMedCrossRef
18.
go back to reference Peng SY, Li JT, Liu YB, Fang HQ, Wu YL, Peng CH, Wang XB, Qian HR. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. Pancreas 2004;28(1):93–97.PubMedCrossRef Peng SY, Li JT, Liu YB, Fang HQ, Wu YL, Peng CH, Wang XB, Qian HR. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. Pancreas 2004;28(1):93–97.PubMedCrossRef
19.
go back to reference Nikou GC, Toubanakis C, Niklolaou P, Giannatou E, Safioleas M, Mallas E, Polyzos A. VIPomas: An update in diagnosis and management in a series of 11 patients. Hepatogastroenterology 2005;52:1259–1265.PubMed Nikou GC, Toubanakis C, Niklolaou P, Giannatou E, Safioleas M, Mallas E, Polyzos A. VIPomas: An update in diagnosis and management in a series of 11 patients. Hepatogastroenterology 2005;52:1259–1265.PubMed
20.
go back to reference Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999;116:1464–1486.PubMedCrossRef Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999;116:1464–1486.PubMedCrossRef
21.
go back to reference Rood RP, DeLellis RA, Dayal Y, Donowitz M. Pancreatic cholera syndrome due to vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology. Gastroenterology 1988;94:813.PubMed Rood RP, DeLellis RA, Dayal Y, Donowitz M. Pancreatic cholera syndrome due to vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology. Gastroenterology 1988;94:813.PubMed
22.
go back to reference Perry RR, Vinik AI. Clinical review 72: Diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab 1995;80(8):2273–2278.PubMedCrossRef Perry RR, Vinik AI. Clinical review 72: Diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab 1995;80(8):2273–2278.PubMedCrossRef
23.
go back to reference Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Rouseu G, Couturier D, Bonnin A. Pancreatic tumors: Comparison of dual-phase helical CT and endoscopic sonography. Am J Roentgenol 1998;170(5):1315–1322. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Rouseu G, Couturier D, Bonnin A. Pancreatic tumors: Comparison of dual-phase helical CT and endoscopic sonography. Am J Roentgenol 1998;170(5):1315–1322.
24.
go back to reference King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol 1994;49(5):295–303.PubMedCrossRef King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol 1994;49(5):295–303.PubMedCrossRef
25.
go back to reference Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: Selection of MR imaging sequences for optimal sensitivity. Radiology 2000;214(2):483–490.PubMed Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: Selection of MR imaging sequences for optimal sensitivity. Radiology 2000;214(2):483–490.PubMed
26.
go back to reference Capella C, Polak JM. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural and biochemical study of 32 cases. Cancer 1983;52:1860–1874.PubMedCrossRef Capella C, Polak JM. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural and biochemical study of 32 cases. Cancer 1983;52:1860–1874.PubMedCrossRef
27.
go back to reference Jensen RT. Pancreatic endocrine tumors: Recent advances. Ann Oncol 1999;10:6 (Suppl). Jensen RT. Pancreatic endocrine tumors: Recent advances. Ann Oncol 1999;10:6 (Suppl).
28.
go back to reference Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty year experience. Surgery 1988;104:1011–1017.PubMed Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty year experience. Surgery 1988;104:1011–1017.PubMed
29.
go back to reference O’Dorisio T, Mekhjian HA, Gaginella TS. Medical therapy of VIPomas. Endocrinol Metab Clin North Am 1989;18:545–556.PubMed O’Dorisio T, Mekhjian HA, Gaginella TS. Medical therapy of VIPomas. Endocrinol Metab Clin North Am 1989;18:545–556.PubMed
30.
go back to reference Kraenzlin ME, Ch’ng JL, Wood SM, Carr DH, Bloom SR. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985;88(1 Pt 1):185–187.PubMed Kraenzlin ME, Ch’ng JL, Wood SM, Carr DH, Bloom SR. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985;88(1 Pt 1):185–187.PubMed
31.
go back to reference Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111–S114.PubMedCrossRef Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111–S114.PubMedCrossRef
32.
go back to reference Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci 1989;34:28S–39S.PubMedCrossRef Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci 1989;34:28S–39S.PubMedCrossRef
33.
go back to reference Cho KJ, Vinik AI. Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation. Radiology 1990;177(2):549–553.PubMed Cho KJ, Vinik AI. Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation. Radiology 1990;177(2):549–553.PubMed
34.
go back to reference Cavallo-Perin P, De Paoli M, Guiso G, Sapino A, Papotti M, Coda R, Pagano G. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report. Cancer 1988;62(12):2576–2579.PubMedCrossRef Cavallo-Perin P, De Paoli M, Guiso G, Sapino A, Papotti M, Coda R, Pagano G. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report. Cancer 1988;62(12):2576–2579.PubMedCrossRef
35.
go back to reference Christensen C. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report. Acta Chir Scand 1989;155(10):541–543.PubMed Christensen C. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report. Acta Chir Scand 1989;155(10):541–543.PubMed
36.
go back to reference Tjon A Tham RT, Jansen JB, Falke TH, Roelfsema F, Griffioen G, van den Sluys Veer A, Lamers CB. MR, CT, and ultrasound findings of metastatic vipoma in pancreas. J Comput Assist Tomogr 1989;13(1):142–144.CrossRef Tjon A Tham RT, Jansen JB, Falke TH, Roelfsema F, Griffioen G, van den Sluys Veer A, Lamers CB. MR, CT, and ultrasound findings of metastatic vipoma in pancreas. J Comput Assist Tomogr 1989;13(1):142–144.CrossRef
37.
go back to reference Venkatesh S, Vassilopoulou-Sellin R, Samaan NA. Somatostatin analogue: use in the treatment of vipoma with hypercalcemia Am J Med 1989;87(3):356–357.PubMedCrossRef Venkatesh S, Vassilopoulou-Sellin R, Samaan NA. Somatostatin analogue: use in the treatment of vipoma with hypercalcemia Am J Med 1989;87(3):356–357.PubMedCrossRef
38.
go back to reference Maltese JY, Monge G, Giraud P, Salers P, Ouafik LH, Pelen F, Oliver C. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP). Clin Endocrinol (Oxf) 1990;33(4):467–480.CrossRef Maltese JY, Monge G, Giraud P, Salers P, Ouafik LH, Pelen F, Oliver C. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP). Clin Endocrinol (Oxf) 1990;33(4):467–480.CrossRef
39.
go back to reference Bramley PN, Lodge JP, Losowsky MS, Giles GR. Treatment of metastatic vipoma by liver transplantation. Clin Transplant 1990;4(5 part 1):276–278; discussion 279.PubMed Bramley PN, Lodge JP, Losowsky MS, Giles GR. Treatment of metastatic vipoma by liver transplantation. Clin Transplant 1990;4(5 part 1):276–278; discussion 279.PubMed
40.
go back to reference Yanagi H, Kusunoki M, Sakanoue Y, Shoji Y, Yamamura T, Murai M, Kikkawa N, Utsunomiya J. Vipoma of the pancreas complicating ulcerative colitis. Am J Gastroenterol 1991;86(8):1066–1069.PubMed Yanagi H, Kusunoki M, Sakanoue Y, Shoji Y, Yamamura T, Murai M, Kikkawa N, Utsunomiya J. Vipoma of the pancreas complicating ulcerative colitis. Am J Gastroenterol 1991;86(8):1066–1069.PubMed
41.
go back to reference Brunani A, Crespi C, De Martin M, Dubini A, Piolini M, Cavagnini F. Four year treatment with a long acting somatostatin analogue in a patient with Verner–Morrison syndrome. J Endocrinol Invest 1991;14(8):685–689.PubMed Brunani A, Crespi C, De Martin M, Dubini A, Piolini M, Cavagnini F. Four year treatment with a long acting somatostatin analogue in a patient with Verner–Morrison syndrome. J Endocrinol Invest 1991;14(8):685–689.PubMed
42.
go back to reference Bani Sacchi T, Bani D, Biliotti G. Immunocytochemical and ultrastructural abnormalities of islet tissue in patients with VIP-producing tumors of the pancreas. Pancreas 1992;7(5):601–610.PubMedCrossRef Bani Sacchi T, Bani D, Biliotti G. Immunocytochemical and ultrastructural abnormalities of islet tissue in patients with VIP-producing tumors of the pancreas. Pancreas 1992;7(5):601–610.PubMedCrossRef
43.
go back to reference Udelsman R, Yeo CJ, Hruban RH, Pitt HA, Niederhuber JE, Coleman J, Cameron JL. Pancreaticoduodenectomy for selected pancreatic endocrine tumors. Surg Gynecol Obstet 1993;177(3):269–278.PubMed Udelsman R, Yeo CJ, Hruban RH, Pitt HA, Niederhuber JE, Coleman J, Cameron JL. Pancreaticoduodenectomy for selected pancreatic endocrine tumors. Surg Gynecol Obstet 1993;177(3):269–278.PubMed
44.
go back to reference Antonelli A, Gambuzza C, Bertoni F, Baschieri L. Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome. J Endocrinol Invest 1993;16(1):57–59.PubMed Antonelli A, Gambuzza C, Bertoni F, Baschieri L. Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome. J Endocrinol Invest 1993;16(1):57–59.PubMed
45.
go back to reference Brunt LM, Mazoujian G, O’Dorisio TM, Wells SA Jr. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome. Surgery 1994;115(3):362–369.PubMed Brunt LM, Mazoujian G, O’Dorisio TM, Wells SA Jr. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome. Surgery 1994;115(3):362–369.PubMed
46.
go back to reference Cesani F, Ernst R, Walser E, Villanueva-Meyer J. Tc-99m sestamibi imaging of a pancreatic VIPoma and parathyroid adenoma in a patient with multiple type I endocrine neoplasia. Clin Nucl Med 1994;19(6):532–534.PubMedCrossRef Cesani F, Ernst R, Walser E, Villanueva-Meyer J. Tc-99m sestamibi imaging of a pancreatic VIPoma and parathyroid adenoma in a patient with multiple type I endocrine neoplasia. Clin Nucl Med 1994;19(6):532–534.PubMedCrossRef
47.
go back to reference Crowley PF, Slavin JL, Rode J. Massive amyloid deposition in pancreatic vipoma: a case report. Pathology 1996;28(4):377–379.PubMedCrossRef Crowley PF, Slavin JL, Rode J. Massive amyloid deposition in pancreatic vipoma: a case report. Pathology 1996;28(4):377–379.PubMedCrossRef
48.
go back to reference Kirkpatrick AW, Hanna SS, Skinner BA. Surgical treatment of pancreatic cholera: a case report. Can J Surg 1996;39(2):155–158.PubMed Kirkpatrick AW, Hanna SS, Skinner BA. Surgical treatment of pancreatic cholera: a case report. Can J Surg 1996;39(2):155–158.PubMed
49.
go back to reference Sofka CM, Semelka RC, Marcos HB, Woosley JT. MR imaging of metastatic pancreatic VIPoma. Magn Reson Imaging 1997;15(10):1205–1208.PubMedCrossRef Sofka CM, Semelka RC, Marcos HB, Woosley JT. MR imaging of metastatic pancreatic VIPoma. Magn Reson Imaging 1997;15(10):1205–1208.PubMedCrossRef
50.
go back to reference Virgolini I, Kurtaran A, Leimer M, Kaserer K, Peck-Radosavljevic M, Angelberger P, Hubsch P, Dvorak M, Valent P, Niederle B. Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy. J Nucl Med 1998;39(9):1575–1579.PubMed Virgolini I, Kurtaran A, Leimer M, Kaserer K, Peck-Radosavljevic M, Angelberger P, Hubsch P, Dvorak M, Valent P, Niederle B. Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy. J Nucl Med 1998;39(9):1575–1579.PubMed
51.
go back to reference Hengst K, Nashan B, Avenhaus W, Ullerich H, Schlitt HJ, Flemming P, Pichlmayr R, Domschke W. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation. Z Gastroenterol 1998;36(3):239–245.PubMed Hengst K, Nashan B, Avenhaus W, Ullerich H, Schlitt HJ, Flemming P, Pichlmayr R, Domschke W. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation. Z Gastroenterol 1998;36(3):239–245.PubMed
52.
go back to reference Huang YH, Lee CH, Wu JC, Wang YJ, Chang FY, Lee SD. Functional pancreatic islet cell tumors with liver metastasis: the role of cytoreductive surgery and transcatheter arterial chemoembolization: a report of five cases. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61(12):748–754. Huang YH, Lee CH, Wu JC, Wang YJ, Chang FY, Lee SD. Functional pancreatic islet cell tumors with liver metastasis: the role of cytoreductive surgery and transcatheter arterial chemoembolization: a report of five cases. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61(12):748–754.
53.
go back to reference Sjoqvist U, Permert J, Lofberg R, Larsson J, Gadaleanu V, Adrian TE. Life threatening diarrhoea ultimately cured by surgery. Eur J Gastroenterol Hepatol 1998;10(11):963–967.PubMedCrossRef Sjoqvist U, Permert J, Lofberg R, Larsson J, Gadaleanu V, Adrian TE. Life threatening diarrhoea ultimately cured by surgery. Eur J Gastroenterol Hepatol 1998;10(11):963–967.PubMedCrossRef
54.
go back to reference Nguyen HN, Backes B, Lammert F, Wildberger J, Winograd R, Busch N, Rieband H, Matern S. Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options. Dig Dis Sci 1999;44(6):1148–1155.PubMedCrossRef Nguyen HN, Backes B, Lammert F, Wildberger J, Winograd R, Busch N, Rieband H, Matern S. Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options. Dig Dis Sci 1999;44(6):1148–1155.PubMedCrossRef
55.
go back to reference Samal SC, Paul AC, Venkateswari S, Nair S, Venkatramani S, Perakath B, Simon A, Chandy G, Kurian G. VIPoma of pancreas in a child. Indian J Gastroenterol 2000;19(4):194–195.PubMed Samal SC, Paul AC, Venkateswari S, Nair S, Venkatramani S, Perakath B, Simon A, Chandy G, Kurian G. VIPoma of pancreas in a child. Indian J Gastroenterol 2000;19(4):194–195.PubMed
56.
go back to reference Masel SL, Brennan BA, Turner JH, Cullingford GL, Cullen DJ. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea. J Gastroenterol Hepatol 2000;15(4):457–460.PubMedCrossRef Masel SL, Brennan BA, Turner JH, Cullingford GL, Cullen DJ. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea. J Gastroenterol Hepatol 2000;15(4):457–460.PubMedCrossRef
57.
go back to reference Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy: the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors. Clin Nucl Med 2000;25(9):661–664.PubMedCrossRef Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy: the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors. Clin Nucl Med 2000;25(9):661–664.PubMedCrossRef
58.
go back to reference Yeh CN, Chen MF, Chen TC. Surgical treatment of pancreatic vasoactive intestinal polypeptide-secreting tumor: a case report. Hepatogastroenterology 2001;48(38):421–423.PubMed Yeh CN, Chen MF, Chen TC. Surgical treatment of pancreatic vasoactive intestinal polypeptide-secreting tumor: a case report. Hepatogastroenterology 2001;48(38):421–423.PubMed
59.
go back to reference Mortele KJ, Oei A, Bauters W, Timmermans F, Cuvelier C, Kunnen M, Ros PR. Dynamic gadolinium-enhanced MR imaging of pancreatic VIPoma in a patient with Verner–Morrison syndrome. Eur Radiol 2001;11(10):1952–1955.PubMedCrossRef Mortele KJ, Oei A, Bauters W, Timmermans F, Cuvelier C, Kunnen M, Ros PR. Dynamic gadolinium-enhanced MR imaging of pancreatic VIPoma in a patient with Verner–Morrison syndrome. Eur Radiol 2001;11(10):1952–1955.PubMedCrossRef
60.
go back to reference Smith CS, Houston M, Jensen B, Mlinar K, Toulson C, Tillotson LG. A 32-year-old man with copious, watery diarrhea. N C Med J 2001;62(3):134–139.PubMed Smith CS, Houston M, Jensen B, Mlinar K, Toulson C, Tillotson LG. A 32-year-old man with copious, watery diarrhea. N C Med J 2001;62(3):134–139.PubMed
61.
go back to reference Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP. Malignant pancreatic tumors in childhood and adolescence: The memorial Sloan–Kettering experience, 1967 to present. J Pediatr Surg 2002;37(6):887–892.PubMedCrossRef Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP. Malignant pancreatic tumors in childhood and adolescence: The memorial Sloan–Kettering experience, 1967 to present. J Pediatr Surg 2002;37(6):887–892.PubMedCrossRef
62.
go back to reference Ichimura T, Kondo S, Okushiba S, Morikawa T, Katoh H. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome. Int J Gastrointest Cancer 2003;33(2–3):99–102.PubMedCrossRef Ichimura T, Kondo S, Okushiba S, Morikawa T, Katoh H. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome. Int J Gastrointest Cancer 2003;33(2–3):99–102.PubMedCrossRef
63.
go back to reference Drivas I, Mansberg R, Roberts JM. VIPoma: a rare cause of a pancreatic mass. Clin Nucl Med 2004;29(3):201–203.PubMedCrossRef Drivas I, Mansberg R, Roberts JM. VIPoma: a rare cause of a pancreatic mass. Clin Nucl Med 2004;29(3):201–203.PubMedCrossRef
Metadata
Title
Pancreatic VIPomas: Subject Review and One Institutional Experience
Authors
Amir A. Ghaferi
Karen A. Chojnacki
William D. Long
John L. Cameron
Charles J. Yeo
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 2/2008
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0177-0

Other articles of this Issue 2/2008

Journal of Gastrointestinal Surgery 2/2008 Go to the issue